Showing results (71-80 of 209) with videos related to
Sort By:
Pageof 21
Journal of Translational Medicine|December 9, 2010
Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task forceLisa H Butterfield, Mary L Disis, Samir N Khleif, et al.Comparative Medicine|September 19, 2022
Unexpected Liver and Kidney Pathology in C57BL/6J Mice Fed a High-fat Diet and Given Azoxymethane to Induce Colon CancerKimberly S Waggie, Lauren R Corulli, Denise Cecil, et al.Anti-Cancer Agents in Medicinal Chemistry|November 19, 2013
CCL21 and IFNγ recruit and activate tumor specific T cells in 3D scaffold model of breast cancerVy Phan-Lai, Forrest M Kievit, Stephen J Florczyk, et al.Journal of Clinical Immunology|March 21, 2003
Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvantDouglas G McNeel, Keith L Knutson, Kathy Schiffman, et al.Journal of Leukocyte Biology|January 19, 2018
TLR8 ligation induces apoptosis of monocytic myeloid-derived suppressor cellsYushe Dang, Zina J Rutnam, Gregory Dietsch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2011
TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapyHailing Lu, Yi Yang, Ekram Gad, et al.Blood|April 4, 2002
Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancersMary L Disis, Kristine Rinn, Keith L Knutson, et al.Molecular Cancer Therapeutics|October 28, 2003
Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunityMary L Disis, Nathalie Scholler, Amber Dahlin, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 6, 2022
COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating LymphocytesDenise L Cecil, Ekram A Gad, Lauren R Corulli, et al.Journal for Immunotherapy of Cancer|December 6, 2018
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the ArtLisa H Butterfield, Mary L Disis, Bernard A Fox, et al.Pageof 21